What is the average analyst rating for ASTS?
The average analyst rating is 'Buy' with a consensus target price of $42.82.
Finance / Stocks
AST SpaceMobile (ASTS) is garnering attention from analysts and investors alike. This article summarizes recent market activity, analyst ratings, and insider trading to provide a comprehensive overview of the stock's current standing.
AST SpaceMobile, Inc. (NASDAQ:ASTS) is developing a space-based cellular broadband network. Recent market data shows the stock's volatility and potential for growth.
**Analyst Ratings:** Several analysts have reiterated or initiated coverage on ASTS with positive ratings:
**Insider Trading:** Director Julio A. Torres sold 20,000 shares at $30.73, decreasing their position by 27.54%. This activity is public information, accessible via SEC filings.
**Institutional Investment:** Hedge funds and institutional investors have been actively adjusting their positions in ASTS:
**Financial Metrics:**
The average analyst rating is 'Buy' with a consensus target price of $42.82.
Yes, Director Julio A. Torres sold 20,000 shares on March 10th.
Vanguard Group Inc. and Geode Capital Management LLC are among those who have increased their holdings.
What are your thoughts on AST SpaceMobile's potential? Do you think the analyst ratings accurately reflect the company's prospects? Share this article with others who need to stay ahead of this trend!
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.